Continuous Glucose Monitoring Systems Market to expand at a CAGR of 12.1% by 2020

Continuous glucose monitoring (CGM) device is a system which measures glucose levels in interstitial fluid that is present between the cells of skin and displays it on monitor. The continuous glucose monitoring systems are used to measure the glucose level of diabetic patients in both hypoglycemia and hyperglycemia stage. In terms of revenue the global continuous glucose monitoring systems market was valued at US$ 402.0 Mn in 2014, and is estimated to be worth US$ 788.4 Mn by 2020.

On the basis of end use sector, global continuous glucose monitoring systems market segmented into household and hospitals & diagnosis centers. Household segment is forecasted to dominate the continuous glucose monitoring systems market throughout the forecast period exhibiting a CAGR of 11.9% in value terms. The household segment was valued at US$ 275 Mn in 2014 and expected to reach US$ 538 Mn by 2020.

With over 40% share in the global continuous glucose monitoring systems, transmitter & monitor was the largest component sub-segment in 2014 followed by insulin pumps. Moreover, the transmitter & monitor is anticipated to grow at a CAGR of 11.9% in terms of value, during the forecast period owing to the advantages and convenience offered by the continuous glucose monitoring systems. Meanwhile, sensors is anticipated to grow with a highest CAGR of 13.9% value wise during the forecast period.

Request For Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-694

In terms of market footprint of several players operating in the global continuous glucose monitoring systems market, Abbott is foreseen to register higher CAGR of 13.1% during the forecast period. Abbott’s CGM brands FreeStyle Navigator and FreeStyle Libre Flash has gained popularity in both household and commercial buyers of CGM systems. Moreover, Medtronic is forecast to dominate the global continuous glucose monitoring systems market with over 39% market value share throughout the forecast period. Medtronic’s revenue from CGM systems is estimated over US$ 150 Mn in 2014, and is anticipated to account for a market share in the range of 45% - 50% by 2020.

Region wise North America dominated the global continuous glucose monitoring systems market in 2014, accounting for about 59% of the revenue share in 2014. However, in terms of revenue Asia Pacific Excluding Japan (APEJ) is foreseen to witness relatively high CAGR of 13.7% during the forecast period.

Send an Enquiry @ http://www.futuremarketinsights.com/askus/rep-gb-694

Based on the end use segments and components the report analyze the attractiveness of each segment using attractiveness tool. Furthermore, all the end use, component and company segments are analyzed in terms of Basis Points to understand individual segments relative contributions to market growth. This detailed level of information is important for the identification of various key trends of the global continuous glucose monitoring systems market.

All the above sections, evaluate the present scenario and the growth prospects of the global continuous glucose monitoring market for the period 2015 to 2020.